BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 3, 2019
View Archived Issues
Meta-analysis reveals universally altered genes in early AD
Read More
New cholesterol target works independently of LDL receptor
Read More
Celyad opens enrollment in phase I trial of CYAD-1 for relapsed/refractory AML or MDS
Read More
Akari announces trial design for pivotal phase III study of nomacopan in pediatric HSCT-TMA
Read More
BiomX completes enrollment in cosmetic clinical study of BX-001 in acne-prone skin
Read More
Funding supports LUNAC-led project to develop next-generation anticoagulant
Read More
Neurocrine Biosciences and Xenon collaborate to develop first-in-class treatments for epilepsy
Read More
Noxopharm announces promising data from DARRT-1 study of Veyonda in prostate cancer
Read More
Seattle Genetics, Astellas, Merck & Co. collaborate to study enfortumab + Keytruda in bladder cancer
Read More
Phase IIa study of masupirdine in moderate Alzheimer's disease misses primary endpoint
Read More
Novel acute challenge mouse model to assess malaria T-cell vaccine antigens in mice
Read More
First report of a schistosome target activated by schistosomes
Read More
Phase II results for tislelizumab plus chemotherapy in GC/GEJC and ESCC
Read More
SHR-1210 plus apatinib as promising first-line treatment for advanced lung squamous carcinoma
Read More
Gilead identifies new Mcl-1 inhibitors
Read More
New Bruton tyrosine kinase inhibitors discovered at Biogen
Read More
Novo Nordisk patents melanocortin MC4 receptor agonists
Read More
Arbutus Biopharma discloses anti-HBV/HDV compounds
Read More
Nitric oxide production enhancers identified at Gurus Biopharm
Read More
One-year data reported for clinical trial of Pfs230D1M-EPA/AS01 malaria vaccination regimen
Read More
Enterotoxigenic E. coli vaccine Etvax in children and infants from Bangladesh: phase I/II results
Read More
Darobactin, new antibiotic against Gram-negative pathogens from Photorhabdus nematode symbionts
Read More
TAF1 is crucial for AML1-ETO-driven leukemogenesis
Read More
Dosing begins in phase I study of UCART-22 in relapsed/refractory B-ALL
Read More
OSE-127 phase I data pave way for phase II studies in ulcerative colitis and Sjogren's syndrome
Read More
NantKwest reports first safety data from phase I trial of PD-L1 t-haNK in solid tumors
Read More